Harrow Eye

Free public records show Harrow Eye in 3 of the markets we cover. It is not a key player in our research.

Public data

Free public data on Harrow Eye

From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.

About our sources

US drug approvals

17 approvals with a product on the US market

  • Byqlovi NDA218158 · approved 4 Mar 2024
  • Vevye NDA217469 · approved 30 May 2023
  • Iheezo NDA216227 · approved 27 Sep 2022
  • Tyrvaya NDA213978 · approved 15 Oct 2021
  • Verkazia NDA214965 · approved 23 Jun 2021

Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.

See them on openFDA (opens in a new tab)

Markets where public records show them

Markets we cover where free public records show Harrow Eye: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.

Topics

The topics of the markets Harrow Eye is in.

All topics

Search all reports for Harrow Eye All companies